Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Deans & Lyons LLP
DALLAS, Feb. 19, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Forest Laboratories, Inc. (NYSE: FRX) in connection the Actavis plc buyout for $26.04 and 0.3306 shares of Actavis. Concerned FRX investors are encouraged to contact attorney Hamilton Lindley by clicking here.
"The potential investigation concerns whether the proposed deal properly values Forest's common stock," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Forest Laboratories, Inc. shareholders receive the highest price reasonably available for their stock."
Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. FRX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at email@example.com or 877-819-8033 with questions or concerns.
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
©2012 PR Newswire. All Rights Reserved.